Showing results (1791-1800 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|July 2, 2026
Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple MyelomaIrene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing, et al.
Transplantation and Cellular Therapy|July 9, 2026
FEASIBILITY AND INTERIM SAFETY AND EFFICACY ANALYSIS OF A FAST AUTOMATED PRODUCTION OF PROPHYLACTIC CMV-SPECIFIC CTLs AFTER ALLOGENEIC HSCTMa Aránzazu Bermúdez, Oscar M Pello, Miriam Sánchez-Escamilla, et al.
Transplantation and Cellular Therapy|July 21, 2026
Significance of CD34+ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD StatusMargery Gang, Megan Othus, Anne-Chloe Olix, et al.
Transplantation and Cellular Therapy|July 17, 2026
ASCT, CAR T-cell, or Combined Consolidation for R/R PCNSL in Re-achieved CR: An Inverse Probability of Treatment Weighting-Adjusted Comparative StudyFan Yang, Rui Liu, Zhonghua Fu, et al.
Transplantation and Cellular Therapy|July 23, 2026
Exercise Duration During a Brief Step Test Independently Predicts Outcomes After Hematopoietic Cell TransplantationZhenmei Zhang, Mehrdad Hefazi Torghabeh, William J Hogan, et al.
Transplantation and Cellular Therapy|August 31, 2026
Gp120-Activated Allogeneic Regulatory T cells for Prevention of Graft-versus-Host-Disease - a First-in-Human TrialAndrea Tuettenberg, Leo Ruhnke, Janine Schlöder, et al.
Transplantation and Cellular Therapy|September 5, 2026
Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD ProphylaxisYaqeen Abduallah, David Allan, Harold Atkins, et al.
Transplantation and Cellular Therapy|August 6, 2026
Large B-Cell Lymphoma After CD19 CAR-T Failure: Updated Real-World Outcomes, Prognostic Factors, and Prediction ModelsSmith Kungwankiattichai, Sanjog Bastola, Manoj Rai, et al.
Transplantation and Cellular Therapy|August 9, 2026
Reduced Cumulative Post-Transplant Cyclophosphamide Exposure Is Associated with Increased Acute and Chronic Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationD Soto, D Gallardo, P Lara, et al.
Transplantation and Cellular Therapy|August 24, 2026
Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T cell depleted Matched Unrelated Donor Haematopoietic Cell TransplantationJonathan A M Lucas, Shelley Hewerdine, Diana F Voiniciuc, et al.
Pageof 183